| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Eckert & Ziegler Strahlen und Medizintechnik AG
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
Cash from Operating Activities
Eckert & Ziegler Strahlen und Medizintechnik AG
Cash from Operating Activities Peer Comparison
AFX
SBS
SHL
DRW8
SRT
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Cash from Operating Activities
€38m
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Cash from Operating Activities
€12.4m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-16%
|
|
|
Stratec SE
XETRA:SBS
|
Cash from Operating Activities
€15.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-5%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Cash from Operating Activities
€1.9B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Cash from Operating Activities
€227.4m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
34%
|
CAGR 10-Years
8%
|
|
|
Sartorius AG
XETRA:SRT
|
Cash from Operating Activities
€697.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
17%
|
CAGR 10-Years
20%
|
See Also
What is Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities?
Cash from Operating Activities
38m
EUR
Based on the financial report for Mar 31, 2024, Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities amounts to 38m EUR.
What is Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
Over the last year, the Cash from Operating Activities growth was 9%. The average annual Cash from Operating Activities growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been 10% over the past three years , 6% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
